Evidence map›Paper›PMID 40521028›Full record

Observational studyFrontiers in cellular and infection microbiology2025

Impact of overlapping fungal infection on the occurrence and prognosis of carbapenem-resistant gram-negative bacilli infection.

Jiahuan Li, Yushan Liu, Tingting Xu, Hongling Ma, Qian Zhang, Lijuan Xiong

Abstract readObservational Study
In one paragraph

Observational study in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiahuan Li *Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Yushan Liu *Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Tingting XuDepartment of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Hongling MaDepartment of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Qian Zhang *Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Lijuan Xiong *Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The global threat of carbapenem-resistant gram-negative bacteria (CRGNB) infection is compounded by concurrent fungal infections, which present additional clinical challenges. This study aims to elucidate the impact of fungal infection on the occurrence and prognosis of CRGNB infection. Methods: We conducted a retrospective, single-center, observational cohort study of 2,273 patients with CRGNB and/or fungal infection from January 2018 to April 2023. Binary logistic regression analysis and multivariable Cox proportional hazards regression model were used to determine risk factors for the occurrence and prognosis of patients with CRGNB or fungal infections. Survival analysis was performed to investigate the impact of fungal co-infection on mortality of total GRGNB and bacterial subclasses infections. Results: Fungal infection was a independent risk factor for CRGNB infection (OR=1.381, Conclusions: In the current study, it was discovered that fungal infections preceded GRGNB infections and might contribute to the development of antibiotic resistance in some gram-negative bacteria, which ultimately leads to more severe clinical outcomes.

Indexed as

CarbapenemsCoinfectionGram-Negative Bacterial InfectionsMycosesAdultAgedAged, 80 and overAnti-Bacterial AgentsDrug Resistance, BacterialFemaleGram-Negative BacteriaHumansMaleMiddle AgedPrognosisRetrospective StudiesAnti-Bacterial AgentsCarbapenemscarbapenem-resistant gram-negative bacillifungal infectionoverlapping infectionprognosisrisk factor

Identifiers

PMID40521028
PMCPMC12162572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.